BLOG

Facioscapulohumeral muscular dystrophy (FSHD) is a genetic or hereditary neuromuscular condition marked by gradual muscular weakening, predominantly impacting the facial region, shoulders, and upper arms. With an incidence of 1 in 8,000 to 22,000 persons, it ranks as the third most prevalent muscular dystrophy.  Symptoms frequently manifest throughout adolescence or early adulthood, although their severity varies significantly. Although incurable, focused care can improve quality of life.

Causes of Facioscapulohumeral Muscular Dystrophy 

FSHD arises from a genetic mutation on chromosome 4, leading to abnormal expression of the DUX4 gene, which damages muscle cells. Key factors include:

• Autosomal Dominant Inheritance: A child has a fifty percent chance of inheriting the mutation if one parent carries the gene.
• Spontaneous Mutations: 10–30% of cases occur without a family history.
• Epigenetic Factors: Chromosome structure alterations enable DUX4 activation, triggering muscle degeneration.

Symptoms of Facioscapulohumeral muscular dystrophy 

Symptoms progress asymmetrically and may include:

• Facial Weakness: Difficulty closing eyes, whistling, or puckering lips.
• Scapular Winging: Prominent shoulder blades due to weakened stabilising muscles.
• Upper Body Weakness: Reduced ability to lift arms overhead or perform daily tasks like brushing hair.
• Lower Body Involvement: Hip and leg weakness in advanced stages, leading to a waddling gait.
• Extramuscular Issues: Rare complications include hearing loss, retinal vasculopathy, or respiratory compromise. 

Diagnosis of Facioscapulohumeral muscular dystrophy 

Diagnosing FSHD involves:

Physical exams: Checking for muscle weakness, scapular winging, or the “Beevor sign” (navel moves upward when flexing neck muscles)6.

Genetic testing: Confirming mutations in the DUX4 gene or shortened D4Z4 repeats on chromosome 4.

Imaging: MRI or ultrasound to assess muscle degeneration3.

There are two types: FSHD1 (95% of cases) and FSHD2, both linked to abnormal DUX4 gene activity that damages muscle cells6.

Management Strategies 

While no cure exists, therapies aim to slow progression and alleviate symptoms:

Non-Surgical Approaches 

• Physical Therapy: Tailored exercises to maintain mobility and strength.
• Orthopaedic Support: Ankle-foot orthoses for foot drop; scapular braces to improve posture.
• Medications:

• • NSAIDs for pain and inflammation.

• • Oral albuterol to increase muscle mass (though not strength).

• Respiratory Support: BiPAP for breathing difficulties, avoiding oxygen alone in hypercarbia.
• Lifestyle Modifications: Avoiding prolonged inactivity to prevent muscle deterioration.

Surgical Interventions 

• Scapulothoracic Fusion: Improves arm mobility by stabilising shoulder blades.
• Tendon Transfers: Restores function in severely weakened muscles.

Emerging Therapies

• DUX4-Targeted Treatments: Experimental approaches using microRNAs (e.g., miR-675) to suppress toxic gene expression.
• Gene Therapy: Early-stage trials focus on silencing DUX4 or repairing genetic defects.

Prognosis 

FSHD progresses slowly, with most individuals maintaining mobility throughout life. Approximately 20% require wheelchairs, but life expectancy is typically normal. Early diagnosis and multidisciplinary care—integrating physiotherapy, pain management, and psychological support—optimise outcomes.

Key Takeaways

• FSHD is linked to DUX4 gene toxicity, causing progressive muscle atrophy.
• Management prioritises symptom relief, mobility preservation, and adaptive technologies.
• Research into DUX4 inhibition offers hope for future disease-modifying therapies.

By combining current treatments with advances in genetic research, individuals with FSHD can achieve improved functionality and quality of life.

Conclusion

Facioscapulohumeral muscular dystrophy (FSHD) is a progressive condition managed through physical therapy, orthopaedic support, and emerging gene therapies. While incurable, tailored interventions enhance the quality of life and maintain mobility. Ongoing research offers hope for future treatments targeting the DUX4 gene, improving outcomes for those affected.

For enquiries and online appointments, send a message to www.BangaloreShoulderInstitute.com/contact

For informative videos related to Shoulder problems and their treatment options, Sports Injuries and other orthopedic conditions, visit the YouTube channel Bangalore Shoulder Institute – https://www.youtube.com/@BangaloreShoulderInstitute